Balanced news tone
News Sentiment
HNSA sentiment intelligence
Hansa Biopharma AB (publ) news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
News tone and price action are not far from neutral.
76/100 classification confidence.
directly relevant articles
high-authority source matches
-2.1% over one week, -0.9% over four weeks, trend inactive, and near fair-value range.
Adrigo Small & Midcap L/S fell 5.0 percent in June, Hansa Biopharma and Braincool contributed the most positively
Market Reaction
Balanced read
News tone and price action are not far from neutral.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
Adrigo Small & Midcap L/S fell 5.0 percent in June, Hansa Biopharma and Braincool contributed the most positively
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 09 Jul 2026 11:13
- Source
- marketscreener.com
Hansa Biopharma to host Q2 2026 interim results conference call
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 08 Jul 2026 09:31
- Source
- marketscreener.com
Hansa Biopharma’s Maria Törnsén speaks at renal summit July 8
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 02 Jul 2026 07:00
- Source
- Stock Titan
Hansa hands SERB Europe and MENA rights to Idefirix in €115M deal
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 01 Jul 2026 07:00
- Source
- Stock Titan
Hansa Biopharma Names Veteran Biotech Executive Adam Cutler as New CFO
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 16 Jun 2026 07:00
- Source
- The Globe and Mail
Hansa Biopharma invite to Capital Markets Day 2026 in New York
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 12 Jun 2026 07:00
- Source
- marketscreener.com
Hansa Biopharma appoints Head of Business Development from AstraZeneca
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 10 Jun 2026 07:00
- Source
- marketscreener.com
Hansa Biopharma participating in Jefferies Global Healthcare Conference in New York
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 02 Jun 2026 07:00
- Source
- marketscreener.com
Analysts Just Made A Massive Upgrade To Their Hansa Biopharma AB (publ) (STO:HNSA) Forecasts
- Tone
- Positive 66/100
- Event
- Analyst action
- Published
- 29 May 2026 07:00
- Source
- simplywall.st
Hansa Biopharma trial results to be presented at ATC in June
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 26 May 2026 07:00
- Source
- Investing.com Nigeria
Sweden's Hansa strikes $134 million deal with SERB for kidney drug
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 19 May 2026 07:00
- Source
- Reuters
Hansa Biopharma (OM:HNSA) Heavy Net Loss Tests Bullish Revenue Growth Narrative
- Tone
- Positive 66/100
- Event
- Earnings
- Published
- 24 Apr 2026 07:00
- Source
- simplywall.st
Earnings call transcript: Hansa Biopharma Q3 2025 revenue drops 37%, stock tumbles
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 30 Oct 2025 07:00
- Source
- Investing.com UK
Hansa Biopharma intends to carry out directed share issue of approximately 10 million shares and has entered into non-binding terms with NovaQuest to restructure debt
- Tone
- Neutral 50/100
- Event
- Balance sheet
- Published
- 18 Jun 2025 07:00
- Source
- TradingView
Hansa Medical AB (HNSBF) Stock Price, News & Analysis
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 25 Apr 2025 00:44
- Source
- Stock Titan
Hansa Biopharma AB: Target Price Consensus and Analysts Recommendations | HNSA | SE0002148817
- Tone
- Neutral 50/100
- Event
- Analyst action
- Published
- 24 Jan 2024 04:23
- Source
- marketscreener.com
Technical Analysis of Hansa Biopharma AB (OMXSTO:HNSA)
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 07 Jan 2019 00:02
- Source
- TradingView